Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Anti-CD44 antisense oligonucleotides prepared by ICN

April 18, 1997

Natural antifungal/antitumor agents discovered by Fujisawa

April 18, 1997

Novartis prepares novel signal transduction inhibitors

April 18, 1997

U.K. launch for Campto

April 18, 1997

Sugen and Hoechst Marion Roussel enter cancer drug research agreement

April 18, 1997

Preclinical and clinical data on p53 presented at AACR

April 17, 1997

C225 effective in mouse model of human bladder cancer

April 16, 1997

ImClone reports research results from its anti-flk-1 monoclonal antibody program

April 16, 1997

Oxford Molecular Group and ImmunoGen join efforts in humanized antibody development

April 16, 1997

DiagnoCure licenses growth factor derivatives for cancer diagnosis/therapy

April 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...